BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
BPI Events
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
Recent in
Upstream
See all
turbulent flow image
Bioreactors
Lessons in Bioreactor Scale-Up, Part 2: A Refresher on Fluid Flow and Mixing
Lessons in Bioreactor Scale-Up, Part 2: A Refresher on Fluid Flow and Mixing
by
Muhammad Arshad Chaudhry
Jun 12, 2024
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
Recent in
Downstream
See all
Thermo Fisher/AstraZeneca webinar title slide
Chromatography
Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography Media
Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography Media
by
BPI Contributor
Jun 6, 2024
30 Min View
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
thumbnail
Bioprocess Insider
KBI extends pharma contract with a $250m purchasing commitment
KBI extends pharma contract with a $250m purchasing commitment
by
Josh Abbott
Jul 25, 2024
2 Min Read
thumbnail
Bioprocess Insider
Alcami expands storage capacity at new RTP location
Alcami expands storage capacity at new RTP location
by
Josh Abbott
Jul 25, 2024
2 Min Read
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
Recent in
Analytical
See all
PRI/HCP eBook cover wide
Process Development
eBook: Host Cell Proteins — Moving from Detection to Knowledge-Building
eBook: Host Cell Proteins — Moving from Detection to Knowledge-Building
by
Derrick Zhang,
Shankar Sellappan
and 3 more
Jul 26, 2024
hand cleaning equipment
QA/QC
Extending the Visible Residue Limit Approach to Potent Therapeutic Proteins — Part 2: Test Results and Conclusions
Extending the Visible Residue Limit Approach to Potent Therapeutic Proteins — Part 2: Test Results and Conclusions
by
Ram Kouda,
Syeda Tabassum
and 3 more
Jun 12, 2024
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
Recent in
Business
See all
Resilience logo
Sponsored Content
Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience
Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience
by
BPI Contributor
Jun 25, 2024
15 Min View
scientist at computer
Bioregions
US–India Collaborative Innovations for Rapid Drug Discovery
US–India Collaborative Innovations for Rapid Drug Discovery
by
Jitendra Kumar
Jun 12, 2024
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
thumbnail
Bioprocess Insider
Biomanufacturing in space accelerating therapy development on Earth
Biomanufacturing in space accelerating therapy development on Earth
by
Josh Abbott
Jul 24, 2024
3 Min Read
iStock photo
Cell Therapies
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 2 — Starting Materials and Drug Substances
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 2 — Starting Materials and Drug Substances
by
Brent Morse,
Alicja Fiedorowicz
Jun 19, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Global Markets
US BIOSECURE Act: Navigating challenges and opportunities
US BIOSECURE Act: Navigating challenges and opportunities
by
Shreeyashi Ojha
Jul 26, 2024
2 Min Read
thumbnail
Bioprocess Insider
KBI extends pharma contract with a $250m purchasing commitment
KBI extends pharma contract with a $250m purchasing commitment
by
Josh Abbott
Jul 25, 2024
2 Min Read
Home
Bioprocess Insider
Therapeutic Class
Therapeutic Class
Novartis growing CAR-T network amid slow Kymriah sales
Global Markets
Novartis growing CAR-T network amid slow Kymriah sales
Novartis growing CAR-T network amid slow Kymriah sales
by
Dan Stanton
Oct 22, 2018
|
2 Min Read
Roche ups cell therapy interest through SQZ expansion deal
Deal Making
Roche ups cell therapy interest through SQZ expansion deal
Roche ups cell therapy interest through SQZ expansion deal
by
Dan Stanton
Oct 19, 2018
2 Min Read
MaSTherCell wins Iovance deal as commercial cell therapy demand increases
Therapeutic Class
MaSTherCell wins Iovance deal as commercial cell therapy demand increases
MaSTherCell wins Iovance deal as commercial cell therapy demand increases
by
BPI Staff
Oct 19, 2018
1 Min Read
Aglaris talks automated and closed cell therapy platform
Upstream & Downstream Processing
Aglaris talks automated and closed cell therapy platform
Aglaris talks automated and closed cell therapy platform
by
Dan Stanton
Oct 18, 2018
3 Min Read
Novartis’ Kymriah partner doubling capacity on global viral vector demand
Facilities & Capacity
Novartis’ Kymriah partner doubling capacity on global viral vector demand
Novartis’ Kymriah partner doubling capacity on global viral vector demand
by
Dan Stanton
Oct 16, 2018
2 Min Read
Merck drops Lantus biosimilar, blames pricing and production cost concerns
Global Markets
Merck drops Lantus biosimilar, blames pricing and production cost concerns
Merck drops Lantus biosimilar, blames pricing and production cost concerns
by
Dan Stanton
Oct 15, 2018
3 Min Read
Deal Making
BMS invests in Compugen, grants access to Opdivo for combo trial
BMS invests in Compugen, grants access to Opdivo for combo trial
Oct 15, 2018
|
2 Min Read
by
Dan Stanton
Bioprocess Insider
Biosimilar round-up: Deal-breaking, approvals, and patents
Biosimilar round-up: Deal-breaking, approvals, and patents
Oct 12, 2018
|
2 Min Read
by
Dan Stanton
Facilities & Capacity
In-house investments let Synthon keep control of ADC production
In-house investments let Synthon keep control of ADC production
Oct 10, 2018
|
2 Min Read
by
BPI Staff
Upstream & Downstream Processing
Hoba (cell) banks on Selexis to advance neuropathic pain program
Hoba (cell) banks on Selexis to advance neuropathic pain program
Oct 9, 2018
|
2 Min Read
by
Dan Stanton
Therapeutic Class
Yescarta: Gilead boasts 60 CAR-T clinics and counting
Yescarta: Gilead boasts 60 CAR-T clinics and counting
Oct 5, 2018
|
3 Min Read
by
Dan Stanton
Regulations
Sanofi and Regeneron gain approval for skin cancer MAb
Sanofi and Regeneron gain approval for skin cancer MAb
Oct 5, 2018
|
2 Min Read
by
BPI Staff
Facilities & Capacity
Double deal with Asterias gives Novo Nordisk CA stem cell plant
Double deal with Asterias gives Novo Nordisk CA stem cell plant
Oct 3, 2018
|
2 Min Read
by
BPI Staff
Therapeutic Class
Pandion selects Just to cut cost of bispecific Ab development
Pandion selects Just to cut cost of bispecific Ab development
Oct 3, 2018
|
2 Min Read
by
Dan Stanton
Deal Making
Alexion refilling pipeline through potential $1.2bn Syntimmune buy
Alexion refilling pipeline through potential $1.2bn Syntimmune buy
Sep 27, 2018
|
2 Min Read
by
BPI Staff
Therapeutic Class
Gene editing deal leaves Thermo Fisher 'unique in offering TALENs and CRISPR’
Gene editing deal leaves Thermo Fisher 'unique in offering TALENs and CRISPR’
Sep 24, 2018
|
2 Min Read
by
Dan Stanton
Deal Making
Eli Lilly on M&A: Balancing the science with the shareholders
Eli Lilly on M&A: Balancing the science with the shareholders
Sep 19, 2018
|
2 Min Read
by
Dan Stanton
Deal Making
Video news: Pall strategic deals aim to enable biosimilar and novel scale-up
Video news: Pall strategic deals aim to enable biosimilar and novel scale-up
Sep 18, 2018
|
2 Min Read
by
Dan Stanton
Deal Making
B-I working with CMO on viral therapies after $245m ViraTherapeutics buy
B-I working with CMO on viral therapies after $245m ViraTherapeutics buy
Sep 17, 2018
|
2 Min Read
by
Dan Stanton
Therapeutic Class
Exclusive: Samsung BioLogics poised to enter cell therapy space
Exclusive: Samsung BioLogics poised to enter cell therapy space
Sep 12, 2018
|
4 Min Read
by
Dan Stanton
Therapeutic Class
Shire buys sanaplasma AG to support immunology business
Shire buys sanaplasma AG to support immunology business
Sep 11, 2018
|
1 Min Read
by
BPI Staff
Global Markets
Sanofi prepped for production after EU Nanobody success
Sanofi prepped for production after EU Nanobody success
Sep 10, 2018
|
2 Min Read
by
Dan Stanton
Therapeutic Class
Vendors ‘awakening’ to the needs of cell and gene therapy makers
Vendors ‘awakening’ to the needs of cell and gene therapy makers
Sep 6, 2018
|
3 Min Read
by
Dan Stanton
Therapeutic Class
False biosimilar communications: Originators rebuff Pfizer’s claims
False biosimilar communications: Originators rebuff Pfizer’s claims
Sep 4, 2018
|
4 Min Read
by
Dan Stanton
Global Markets
Gilead says CA plant will supply Yescarta to EU until 2020
Gilead says CA plant will supply Yescarta to EU until 2020
Aug 30, 2018
|
2 Min Read
by
Dan Stanton